Displaying 1 to 3 of 3 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Gambro |
6 Sep 2013 | Acquisition USD 3,900,000,000 (USD 3,900,000,000) deal size. Initial investment. Led the investment round. Active |
||
|
|
KaloBios Pharmaceuticals Inc Develops first- or best-in-class antibody therapeutics in the fields of autoimmunity |
United States | N/A |
||
|
|
Somatogen Inc A biopharmaceutical company developing synthetic hemoglobin products for use in blood transfusion. |
United States | 24 Feb 1998 | Acquisition 189,000,000 (USD 189,000,000) deal size. |